Your browser doesn't support javascript.
loading
The most efficient and effective BRCA1/2 testing strategy in epithelial ovarian cancer: Tumor-First or Germline-First?
Witjes, Vera M; Ligtenberg, Marjolijn J L; Vos, Janet R; Braspenning, Jozé C C; Ausems, Margreet G E M; Mourits, Marian J E; de Hullu, Joanne A; Adang, Eddy M M; Hoogerbrugge, Nicoline.
Affiliation
  • Witjes VM; Department of Human Genetics, Radboud university medical center, Nijmegen, the Netherlands; Research Institute for Medical Innovation, Radboud university medical center, Nijmegen, the Netherlands.
  • Ligtenberg MJL; Department of Human Genetics, Radboud university medical center, Nijmegen, the Netherlands; Research Institute for Medical Innovation, Radboud university medical center, Nijmegen, the Netherlands; Department of Pathology, Radboud university medical center, Nijmegen, the Netherlands.
  • Vos JR; Department of Human Genetics, Radboud university medical center, Nijmegen, the Netherlands; Research Institute for Medical Innovation, Radboud university medical center, Nijmegen, the Netherlands.
  • Braspenning JCC; Research Institute for Medical Innovation, Radboud university medical center, Nijmegen, the Netherlands; Department of IQ Healthcare, Radboud university medical center, Nijmegen, the Netherlands.
  • Ausems MGEM; Department of Genetics, Division Laboratories, Pharmacy and Biomedical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Mourits MJE; Department of Gynecology, University Medical Center Groningen, Groningen, the Netherlands.
  • de Hullu JA; Research Institute for Medical Innovation, Radboud university medical center, Nijmegen, the Netherlands; Department of Obstetrics and Gynecology, Radboud university medical center, Nijmegen, the Netherlands.
  • Adang EMM; Research Institute for Medical Innovation, Radboud university medical center, Nijmegen, the Netherlands; Department for Health Evidence, Radboud university medical center, Nijmegen, the Netherlands.
  • Hoogerbrugge N; Department of Human Genetics, Radboud university medical center, Nijmegen, the Netherlands; Research Institute for Medical Innovation, Radboud university medical center, Nijmegen, the Netherlands. Electronic address: Nicoline.Hoogerbrugge@radboudumc.nl.
Gynecol Oncol ; 174: 121-128, 2023 07.
Article in En | MEDLINE | ID: mdl-37182432
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / BRCA1 Protein Type of study: Diagnostic_studies / Prognostic_studies Limits: Female / Humans Language: En Journal: Gynecol Oncol Year: 2023 Type: Article Affiliation country: Netherlands
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / BRCA1 Protein Type of study: Diagnostic_studies / Prognostic_studies Limits: Female / Humans Language: En Journal: Gynecol Oncol Year: 2023 Type: Article Affiliation country: Netherlands